AstraZeneca Replies to FDA Complete Response Letter for BRILINTA
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](/images/stories/logo/astrazeneca.gif)
Genzyme to Build Additional Plant to Support Growth of Myozyme® and Lumizyme®
- Details
- Category: Genzyme
![Genzyme Genzyme](/images/stories/logo/genzyme.gif)
The clinical phase III programme commenced on zicronapine
- Details
- Category: Lundbeck
![Lundbeck Lundbeck](/images/stories/logo/lundbeck.gif)
Roche personalized investigational medicine shows survival benefit in advanced skin cancer
- Details
- Category: Roche
![Roche Roche](/images/stories/logo/roche.gif)
Bayer and Regeneron start MYRROR Phase III Trial
- Details
- Category: Bayer
![Bayer Bayer](/images/stories/logo/bayer.gif)
Boehringer Ingelheim to Purchase Amgen's Fremont (California) Facility
- Details
- Category: Amgen
![Amgen Amgen](/images/stories/logo/amgen.gif)
GlaxoSmithKline announces Q4 2010 legal charge
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline GlaxoSmithKline](/images/stories/logo/gsk.gif)
More Pharma News ...
- European Commission Clears Acquisition of Genzyme Corporation by sanofi-aventis
- Boehringer Ingelheim and Eli Lilly and Company Announce Strategic Alliance
- Sandoz announces phase II clinical trial for biosimilar version of rituximab
- GlaxoSmithKline and ChemoCentryx announce initiation of Phase III study of GSK'786
- New Bayer U.S. Innovation Center starts its operations
- People to Actively Manage Their Type 2 Diabetes
- Genzyme Financial Recovery Continues in Fourth Quarter